Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contraceptives and Dolutegravir-based ART

NCT04910711 is registered in ClinicalTrials.gov with Botswana Harvard AIDS Institute Partnership as lead sponsor.

NCT NCT04910711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04910711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contraceptives and Dolutegravir-based ART
Lead sponsor
Botswana Harvard AIDS Institute Partnership
Phase
Phase 4
Overall status
Unknown status
Start date
October 21, 2021
Completion date
October 31, 2024
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

art, contraception, human immunodeficiency virus